Manel Merabet
Cdo SKYMAB Biotherapeutics
Dr. Manel Kraiem Merabet serves as Chief Development Officer, bringing over nine years of translational and clinical research expertise from cancer centers and biotech. Previously, she spent six years as a Senior Project Manager at Innate Pharma, leading ADC projects from optimization to IND. Recognized as an ADC expert, she has been a panelist at the World ADC Congress. She holds a PharmD, a PhD in Oncology and Immunology, a European Radiopharmacy degree, and a Master’s in Organic Chemistry, driving innovative therapeutic development with deep scientific and strategic acumen.
